Photos: 

Some evaluation reports are public and can be downloaded from this website, while others are restricted to MSF users and can only be accessed via Tukul. This limitation is mainly due to the sensitive nature of the operational contexts and the resulting content. However, there are internal discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

In 2010 the operational prospects for OCB (strategic operational plan) outlined the broad objectives for the coming three years and placed renewed attention on key medical areas including surgery and emergency and acute medicine, bringing about increased investment in two hospital programs where OCB focussed on providing emergency surgical care in third level facilities in Tabarre and Kunduz.

This publication was produced at the request of MSF OCB, under the management of the SEU. It was prepared independently by Juan Luis Dominguez and Jon Gunnarsson.
29/10/2015

Between late 2010 and the end of 2014 and under extremely difficult conditions, Médecins sans Frontières (MSF) carried out a project to combat Human African trypanosomiasis (HAT), also known as sleeping sickness, in the Dingila, Ango and Zobia regions of Orientale Province in the Democratic Republic of Congo (DRC). HAT in DRC is caused by Trypanosoma brucei gambiense and is transmitted by the tsetse fly (Glossina genus) of the Palpalis group. Without effective treatment, virtually all first-stage HAT patients and one hundred per cent of second-stage patients will die.

Simon Van Nieuwenhove
19/10/2015

Entre fin 2010 et fin 2014, Médecins sans Frontières (MSF) a, dans des conditions extrêmement difficiles, mené un projet de lutte contre la trypanosomiase humaine africaine (THA) ou maladie du sommeil dans la région de Dingila, Ango et Zobia, dans la Province Orientale de la République Démocratique du Congo (RDC). La THA en RDC est causée par Trypanosoma brucei gambiense et y est transmise par des glossines (mouches tsé-tsé) du groupe palpalis. Sans traitement efficace, quasi tous les malades au premier stade et cent pourcent de malades au deuxième stade de la THA meurent.

Simon Van Nieuwenhove
01/10/2015

Between late 2010 and the end of 2014 and under extremely difficult conditions, Médecins sans Frontières (MSF) carried out a project to combat Human African trypanosomiasis (HAT), also known as sleeping sickness, in the Dingila, Ango and Zobia regions of Orientale Province in the Democratic Republic of Congo (DRC). HAT in DRC is caused by Trypanosoma brucei gambiense and is transmitted by the tsetse fly (Glossina genus) of the Palpalis group. Without effective treatment, virtually all first-stage HAT patients and one hundred per cent of second-stage patients will die.

Simon Van Nieuwenhove
30/09/2015

Entre fin 2010 et fin 2014, Médecins sans Frontières (MSF) a, dans des conditions extrêmement difficiles, mené un projet de lutte contre la trypanosomiase humaine africaine (THA) ou maladie du sommeil dans la région de Dingila, Ango et Zobia, dans la Province Orientale de la République Démocratique du Congo (RDC). La THA en RDC est causée par Trypanosoma brucei gambiense et y est transmise par des glossines (mouches tsé-tsé) du groupe palpalis. Sans traitement efficace, quasi tous les malades au premier stade et cent pourcent de malades au deuxième stade de la THA meurent.

Simon Van Nieuwenhove
30/09/2015
Entre fin 2010 et fin 2014, Médecins sans Frontières (MSF) a, dans des conditions extrêmement difficiles, mené un projet de lutte contre la trypanosomiase humaine africaine (THA) ou maladie du sommeil dans la région de Dingila, Ango et Zobia, dans la Province Orientale de la République Démocratique du Congo (RDC). La THA en RDC est causée par Trypanosoma brucei gambiense et y est transmise par des glossines (mouches tsé-tsé) du groupe palpalis. Sans traitement efficace, quasi tous les malades au premier stade et cent pourcent de malades au deuxième stade de la THA meurent.
by Simon Van Nieuwenhove
21/09/2015

Between late 2010 and the end of 2014 and under extremely difficult conditions, Médecins sans Frontières (MSF) carried out a project to combat Human African trypanosomiasis (HAT), also known as sleeping sickness, in the Dingila, Ango and Zobia regions of Orientale Province in the Democratic Republic of Congo (DRC). HAT in DRC is caused by Trypanosoma brucei gambiense and is transmitted by the tsetse fly (Glossina genus) of the Palpalis group. Without effective treatment, virtually all first-stage HAT patients and one hundred per cent of second-stage patients will die.

by Simon Van Nieuwenhove
16/09/2015

This survey investigates patients’ coping mechanisms and their dependence on medical institutions both from the patients’ standpoint and from that of MSF’s project teams.

Marc Le Pape and Suzanne Bradol
08/07/2015

A series of failures was the starting point for this analysis. Several outbreaks of hepatitis E, transmitted via the water supply, occurred in refugee and IDP sites in the Sahel (Sudan in 2004, and Chad in 2007) and in central Africa (Central African Republic in 2002, and Uganda in 2007). MSF was responsible for all or part of the water supply, as well as medical care. These outbreaks are a reminder that significant infectious risks persists even after we implement our usual procedures.

Jean-Hervé Bradol, Francisco Diaz, Jérôme Léglise, Marc Le Pape
08/07/2015

The purpose of this evaluation was to assess the functioning of the hospital set-up in Léogâne, Haiti one year after its implementation and to capture the lessons learned in order to inform other missions that attempt this type of set-up. The conclusions are based on two visits, the first at the 6-month mark and the second approximately one year following the initial implementation. In general, there is a positive attitude towards the set-up and the advantage of quick and relevant decision-making was felt in most departments at almost all levels.

This evaluation was conducted by Annie Désilets on behalf of the MSF Vienna Evaluation Unit.
01/06/2015

Pages